GIP or not GIP? That is the question

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.3, 2003-03, pp. : 110-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo transfection rat small intestine K-cell with pGIP/Ins plasmid by DOTAP liposome

By Palizban A. A. Salehi R. Nori N. Galehdari H.

Journal of Drug Targeting, Vol. 15, Iss. 5, 2007-06 ,pp. : 351-357

Informa Healthcare

Access to resources Recommend Favorite

Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3651-3662

Bentham Science Publishers

Access to resources Recommend Favorite

Standard antenatal care in question

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 314, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

To switch (statins) or not to switch? That is the question

By Athyros Vasilios G Tziomalos Konstantinos Karagiannis Asterios Mikhailidis Dimitri P

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2943-2946

Informa Healthcare

Access to resources Recommend Favorite

TPE or not TPE? It's no longer a question

By Wood J.G. Sinclair D.A.

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 1-4

Elsevier

Access to resources Recommend Favorite